The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,328.00
Bid: 2,323.00
Ask: 2,325.00
Change: 44.00 (1.93%)
Spread: 2.00 (0.086%)
Open: 2,291.00
High: 2,340.00
Low: 2,284.00
Prev. Close: 2,284.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 07:00

RNS Number : 3498B
Halma PLC
30 January 2024
 

Halma plc ("Halma" or "Company")Directorate Change

 

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.

 

His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.

 

Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.

 

Dame Louise Makin, Chair, commented:"I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.

 

I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors"

 

There are no further details to be disclosed for Giles Kerr under Listing Rule 9.6.13R.

 

 

For further information, please contact:

Halma plcMarc Ronchetti, Group Chief ExecutiveSteve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations

Clayton Hirst, Director of Corporate Affairs

+44 (0)1494 721 111

+44 (0)7776 685948

+44 (0)7834 796 013

MHPOliver Hughes/Rachel Farrington/Ollie Hoare

+44 (0)20 3128 8100

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGFMVGFGDZG
Date   Source Headline
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.